Defining the cardiac fibroblast

Circulation Journal

Volumn 80, Issue 11, 2016, Pages 2269-2276

  Ivey, Malina J ^a   Tallquist, Michelle D ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Cardiac fibroblast; Cardiovascular remodeling; Fibrosis; Myofibroblast

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; DISCOIDIN; FIBRONECTIN; INTEGRIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PEPTIDES AND PROTEINS; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL ANTIGEN 1; THY 1 ANTIGEN; TRANSCRIPTION FACTOR 21; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR TBX18; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG; VIMENTIN; WNT1 PROTEIN; WT1 PROTEIN;

CELL ACTIVATION; CELL FUNCTION; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART FIBROBLAST; HEART MUSCLE FIBROSIS; HUMAN; IMMUNOHISTOCHEMISTRY; PLASTICITY; REVIEW; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; CARDIAC MUSCLE; FIBROBLAST; FIBROSIS; GENE EXPRESSION REGULATION; HEART DISEASE; METABOLISM; PATHOLOGY;

ANIMALS; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; HEART DISEASES; HUMANS; MYOCARDIUM;

EID: 84992453296     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-16-1003     Document Type: Review

References (134)

1. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 2005; 45: 657–687.
2. Haidara MA, Assiri AS, Yassin HZ, Ammar HI, Obradovic MM, Isenovic ER. Heart failure models: Traditional and novel therapy. Curr Vasc Pharmacol 2015; 13: 658–669.
3. Gittenberger-de Groot AC, Bartelings MM, Poelmann RE, Haak MC, Jongbloed MR. Embryology of the heart and its impact on understanding fetal and neonatal heart disease. Semin Fetal Neonatal Med 2013; 18: 237–244.
4. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 2004; 84: 649–698.
5. Van Den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: The role of myofibroblasts. Nat Rev Cardiol 2010; 7: 30–37.
6. Frangogiannis NG. Matricellular proteins in cardiac adaptation and disease. Physiol Rev 2012; 92: 635–688.
7. Snider P, Standley KN, Wang J, Azhar M, Doetschman T, Conway SJ. Origin of cardiac fibroblasts and the role of periostin. Circ Res 2009; 105: 934–947.
8. Hiatt JL, Gartner LP. Color atlas and text of histology. Lippincott Williams & Wilkins, 2013: 58–79.
9. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites. J Immunol 2001; 166: 7556–7562.
10. Varga I, Danisovic L, Kyselovic J, Gazova A, Musil P, Miko M, et al. The functional morphology and role of cardiac telocytes in myocardium regeneration. Can J Physiol Pharmacol 2016 May 19, doi:10.1139/cjpp-2016-0052.
11. Gabbiani G, Ryan G, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971; 27: 549–550.
12. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349–363.
13. Gittenberger-de Groot AC, Vrancken Peeters MP, Mentink MM, Gourdie RG, Poelmann RE. Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ Res 1998; 82: 1043–1052.
14. Mikawa T, Gourdie RG. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol 1996; 174: 221–232.
15. Dettman RW, Denetclaw W, Ordahl CP, Bristow J. Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol 1998; 193: 169–181.
16. Manner J. Does the subepicardial mesenchyme contribute myocar-dioblasts to the myocardium of the chick embryo heart?: A quail-chick chimera study tracing the fate of the epicardial primordium. Anat Rec 1999; 255: 212–226.
17. Perez-Pomares J, Macias D, Garcia-Garrido L, Munoz-Chapuli R. Contribution of the primitive epicardium to the subepicardial mesenchyme in hamster and chick embryos. Dev Dyn 1997; 210: 96–105.
18. Wessels A, van den Hoff MJ, Adamo RF, Phelps AL, Lockhart MM, Sauls K, et al. Epicardially derived fibroblasts preferentially contribute to the parietal leaflets of the atrioventricular valves in the murine heart. Dev Biol 2012; 366: 111–124.
19. Acharya A, Baek ST, Huang G, Eskiocak B, Goetsch S, Sung CY, et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 2012; 139: 2139–2149.
20. Cai CL, Martin JC, Sun Y, Cui L, Wang L, Ouyang K, et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature 2008; 454: 104–108.
21. Smith CL, Baek ST, Sung CY, Tallquist MD. Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circ Res 2011; 108: e15–e26, doi:10.1161/CIRCRESAHA.110.235531.
22. Zhou B, Ma Q, Rajagopal S, Wu SM, Domian I, Rivera-Feliciano J, et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 2008; 454: 109–113.
23. Dymecki S, Ray R, Kim J. Mapping cell fate and function using recombinase-based intersectional strategies. Methods Enzymol 2010; 477: 183.
24. Swonger JM, Liu JS, Ivey MJ, Tallquist MD. Genetic tools for identifying and manipulating fibroblasts in the mouse. Differentiation 2016 June 21, doi:10.1016/j.diff.2016.05.009.
25. Ali SR, Ranjbarvaziri S, Talkhabi M, Zhao P, Subat A, Hojjat A, et al. Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ Res 2014; 115: 625–635.
26. Moore-Morris T, Guimares-Camboa N, Banerjee I, Zambon AC, Kisseleva T, Velayoudon A, et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J Clin Invest 2014; 124: 2921.
27. Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci USA 2006; 103: 18284–18289.
28. Van Amerongen M, Bou-Gharios G, Popa E, Van Ark J, Petersen A, Van Dam G, et al. Bone marrow derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol 2008; 214: 377–386.
29. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13: 952–961.
30. Zhou B, Pu WT. Epicardial epithelial-to-mesenchymal transition in injured heart. J Cell Mol Med 2011; 15: 2781–2783.
31. van Wijk B, Gunst QD, Moorman AF, van den Hoff MJ. Cardiac regeneration from activated epicardium. PLoS One 2012; 7: e44692, doi:10.1371/journal.pone.0044692.
32. Zhou B, Honor LB, He H, Ma Q, Oh JH, Butterfield C, et al. Adult mouse epicardium modulates myocardial injury by secreting para-crine factors. J Clin Invest 2011; 121: 1894–1904.
33. Kanisicak O, Khalil H, Ivey MJ, Karch J, Maliken BD, Correll RN, et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun 2016; 7: 12260.
34. Yata Y, Scanga A, Gillan A, Yang L, Reif S, Breindl M, et al. DNase I-hypersensitive sites enhance α1 (I) collagen gene expression in hepatic stellate cells. Hepatology 2003; 37: 267–276.
35. Lekic P, Pender N, McCulloch C. Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues? J Dent Res 1997; 8: 253–268.
36. Ko SD, Page RC, Narayanan A. Fibroblast heterogeneity and prostaglandin regulation of subpopulations. Proc Natl Acad Sci USA 1977; 74: 3429–3432.
37. Bordin S, Page R, Narayanan A. Heterogeneity of normal human diploid fibroblasts: Isolation and characterization of one phenotype. Science 1984; 223: 171–173.
38. Hassell T, Stanek E. Evidence that healthy human gingiva contains functionally heterogeneous fibroblast subpopulations. Arch Oral Biol 1983; 28: 617–625.
39. Angello JC, Pendergrass WR, Norwood TH, Prothero J. Prolifera-tive potential of human fibroblasts: An inverse dependence on cell size. J Cell Physiol 1987; 132: 125–130.
40. Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT, D’Antoni ML, Debuque R, et al. Revisiting cardiac cellular composition. Circ Res 2016; 118: 400–409.
41. Kaur H, Takefuji M, Ngai C, Carvalho J, Bayer J, Wietelmann A, et al. Targeted ablation of periostin-expressing activated fibroblasts prevents adverse cardiac remodeling in mice. Circ Res 2016; 118: 1906–1917.
42. Hudon-David F, Bouzeghrane F, Couture P, Thibault G. Thy-1 expression by cardiac fibroblasts: Lack of association with myofibroblast contractile markers. J Mol Cell Cardiol 2007; 42: 991–1000.
43. Goldsmith EC, Hoffman A, Morales MO, Potts JD, Price RL, McFadden A, et al. Organization of fibroblasts in the heart. Dev Dyn 2004; 230: 787–794.
44. Kong P, Christia P, Saxena A, Su Y, Frangogiannis NG. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am J Physiol Heart Circ Physiol 2013; 305: H1363–H1372.
45. Furtado MB, Costa MW, Pranoto EA, Salimova E, Pinto AR, Lam NT, et al. Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ Res 2014; 114: 1422–1434.
46. Bagchi RA, Lin J, Wang R, Czubryt MP. Regulation of fibronectin gene expression in cardiac fibroblasts by scleraxis. Cell Tissue Res 2016 June 21, doi:10.1007/s00441-016-2439-1.
47. Goodpaster T, Legesse-Miller A, Hameed MR, Aisner SC, Randolph-Habecker J, Coller HA. An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 2008; 56: 347–358.
48. Vasquez C, Benamer N, Morley GE. The cardiac fibroblast: Functional and electrophysiological considerations in healthy and diseased hearts. J Cardiovasc Pharmacol 2011; 57: 380.
49. Santiago JJ, Dangerfield AL, Rattan SG, Bathe KL, Cunnington RH, Raizman JE, et al. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: Expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev Dyn 2010; 239: 1573–1584.
50. Chapman D, Weber KT, Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ Res 1990; 67: 787–794.
51. Tillmanns J, Hoffmann D, Habbaba Y, Schmitto JD, Sedding D, Fraccarollo D, et al. Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. J Mol Cell Cardiol 2015; 87: 194–203.
52. Ffrench-Constant C, Van de Water L, Dvorak HF, Hynes RO. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 1989; 109: 903–914.
53. Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: The fibroblast awakens. Circ Res 2016; 118: 1021–1040.
54. Braitsch CM, Kanisicak O, van Berlo JH, Molkentin JD, Yutzey KE. Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease. J Mol Cell Cardiol 2013; 65: 108–119.
55. Noseda M, Harada M, McSweeney S, Leja T, Belian E, Stuckey DJ, et al. PDGFR-alpha demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium. Nat Commun 2015; 6: 6930, doi:10.1038/ncomms7930.
56. Lin SL, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617–1627.
57. Birbrair A, Zhang T, Files DC, Mannava S, Smith T, Wang ZM, et al. Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res Ther 2014; 5: 1.
58. Ponticos M, Partridge T, Black CM, Abraham DJ, Bou-Gharios G. Regulation of collagen type I in vascular smooth muscle cells by competition between Nkx2.5 and deltaEF1/ZEB1. Mol Cell Biol 2004; 24: 6151–6161.
59. Hamilton TG, Klinghoffer RA, Corrin PD, Soriano P. Evolutionary divergence of platelet-derived growth factor alpha receptor signaling mechanisms. Mol Cell Biol 2003; 23: 4013–4025.
60. Acharya A, Baek ST, Banfi S, Eskiocak B, Tallquist MD. Efficient inducible Cre-mediated recombination in Tcf21cell lineages in the heart and kidney. Genesis 2011; 49: 870–877.
61. Nag A. Study of non-muscle cells of the adult mammalian heart: A fine structural analysis and distribution. Cytobios 1979; 28: 41–61.
62. Bergmann O, Zdunek S, Felker A, Salehpour M, Alkass K, Bernard S, et al. Dynamics of cell generation and turnover in the human heart. Cell 2015; 161: 1566–1575.
63. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol 2007; 293: H1883–H1891.
64. Baudino TA, Carver W, Giles W, Borg TK. Cardiac fibroblasts: Friend or foe? Am J Physiol Heart Circ Physiol 2006; 291: H1015–H1026.
65. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: The renaissance cell. Circ Res 2009; 105: 1164–1176.
66. Eghbali M. Cardiac fibroblasts: Function, regulation of gene expression, and phenotypic modulation. In: Cardiac adaptation in heart failure. Editors: Holtz J, Drexler H, Just H. Steinkopff Verlag, Darmstadt, 1992: 183–189.
67. Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA, et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 2015; 16: 51–66.
68. Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, et al. Targeting of [alpha]v integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 2013; 19: 1617–1624.
69. Kolditz DP, Wijffels MC, Blom NA, van der Laarse A, Hahurij ND, Lie-Venema H, et al. Epicardium-derived cells in development of annulus fibrosis and persistence of accessory pathways. Circulation 2008; 117: 1508–1517.
70. Zhou B, von Gise A, Ma Q, Hu YW, Pu WT. Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart. Dev Biol 2010; 338: 251–261.
71. Lockhart MM, Phelps AL, van den Hoff MJ, Wessels A. The epicardium and the development of the atrioventricular junction in the murine heart. J Dev Biol 2014; 2: 1–17.
72. Majno G, Gabbiani G, Hirschel B, Ryan G, Statkov P. Contraction of granulation tissue in vitro: Similarity to smooth muscle. Science 1971; 173: 548–550.
73. Lagace R, Delage C, Boutet M. Light and electron microscopic study of cellular proliferation in carcinoid heart disease. Recent Adv Stud Card Struct Metabol 1974; 10: 605–616.
74. Kischer C, Shetlar M. Electron microscopic studies of connective tissue repair after myocardial injury. Tex Rep Biol Med 1978; 39: 357–369.
75. Gabbiani G, Hirschel B, Ryan G, Statkov P, Majno G. Granulation tissue as a contractile organ: A study of structure and function. J Exp Med 1972; 135: 719–734.
76. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122: 103–111.
77. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 1986; 103: 2787–2796.
78. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is tran-siently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990; 63: 21–29.
79. Frangogiannis NG, Michael LH, Entman ML. Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc Res 2000; 48: 89–100.
80. Qiu P, Feng XH, Li L. Interaction of Smad3 and SRF-associated complex mediates TGF-beta signals to regulate SM22 transcription during myofibroblast differentiation. J Mol Cell Cardiol 2003; 35: 1407–1420.
81. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. Expression of smooth muscle-specific proteins in myoepithe-lium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 1993; 90: 999–1003.
82. Sappino A, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990; 63: 144–161.
83. Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 1999; 154: 871–882.
84. Carver W, Nagpal ML, Nachtigal M, Borg TK, Terracio L. Collagen expression in mechanically stimulated cardiac fibroblasts. Circ Res 1991; 69: 116–122.
85. Wang J, Chen H, Seth A, McCulloch CA. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2003; 285: H1871–H1881.
86. Petrov VV, Fagard RH, Lijnen PJ. Stimulation of collagen production by transforming growth factorβ-1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 2002; 39: 258–263.
87. Espira L, Lamoureux L, Jones SC, Gerard RD, Dixon IM, Czubryt MP. The basic helix-loop-helix transcription factor scleraxis regulates fibroblast collagen synthesis. J Mol Cell Cardiol 2009; 47: 188–195.
88. Roche PL, Nagalingam RS, Bagchi RA, Aroutiounova N, Belisle BM, Wigle JT, et al. Role of scleraxis in mechanical stretch-medi-ated regulation of cardiac myofibroblast phenotype. Am J Physiol Cell Physiol 2016; 311: C297–C307.
89. Small EM. The actin-MRTF-SRF gene regulatory axis and myofibroblast differentiation. J Cardiovasc Transl Res 2012; 5: 794–804.
90. van Putten S, Shafieyan Y, Hinz B. Mechanical control of cardiac myofibroblasts. J Mol Cell Cardiol 2016; 93: 133–142.
91. Chen W, Frangogiannis NG. Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta 2013; 1833: 945–953.
92. Gustafsson E, Brakebusch C, Hietanen K, Fassler R. Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci 2001; 114: 671–676.
93. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341–350.
94. Murray IR, Baily JE, Chen WC, Dar A, Gonzalez ZN, Jensen AR, et al. Skeletal and cardiac muscle pericytes: Functions and therapeutic potential. Pharmacol Ther 2016 September 16, doi:10.1016/j. pharmthera.2016.09.005.
95. Desmoulière A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995; 146: 56.
96. Lemos DR, Babaeijandaghi F, Low M, Chang CK, Lee ST, Fiore D, et al. Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors. Nat Med 2015; 21: 786–794.
97. Hecker L, Jagirdar R, Jin T, Thannickal VJ. Reversible differentiation of myofibroblasts by MyoD. Exp Cell Res 2011; 317: 1914–1921.
98. Garrison G, Huang SK, Okunishi K, Scott JP, Kumar Penke LR, Scruggs AM, et al. Reversal of myofibroblast differentiation by prostaglandin e2. Am J Respir Cell Mol Biol 2013; 48: 550–558.
99. Artaud-Macari E, Goven D, Brayer S, Hamimi A, Besnard V, Marchal-Somme J, et al. Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis. Antioxid Redox Signal 2013; 18: 66–79.
100. Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA 2012; 109: 9448–9453.
101. Troeger JS, Mederacke I, Gwak GÄ, Dapito DH, Mu X, Hsu CC, et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 2012; 143: 1073–1083.e22, doi:10.1053/j.gastro.2012.06.036.
102. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008; 454: 646–650.
103. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008; 321: 699–702.
104. Lombardi R, Chen SN, Ruggiero A, Gurha P, Czernuszewicz GZ, Willerson JT, et al. Cardiac fibro-adipocyte progenitors express desmosome proteins and preferentially differentiate to adipocytes upon deletion of the desmoplakin gene. Circ Res 2016; 119: 41–54.
105. Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, Li J, Ahmed I, et al. Adult cardiac-resident MSC-like stem cells with a proepi-cardial origin. Cell Stem Cell 2011; 9: 527–540.
106. Ubil E, Duan J, Pillai IC, Rosa-Garrido M, Wu Y, Bargiacchi F, et al. Mesenchymal-endothelial transition contributes to cardiac neo-vascularization. Nature 2014; 514: 585–590.
107. Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012; 485: 599–604.
108. Chen JX, Krane M, Deutsch MA, Wang L, Rav-Acha M, Gregoire S, et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res 2012; 111: 50–55.
109. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012; 485: 593–598.
110. Joe AW, Yi L, Natarajan A, Le Grand F, So L, Wang J, et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 2010; 12: 153–163.
111. Uezumi A, Fukada SI, Yamamoto N, Takeda Si, Tsuchida K. Mesenchymal progenitors distinct from satellite cells contribute to ecto-pic fat cell formation in skeletal muscle. Nat Cell Biol 2010; 12: 143–152.
112. Yamaguchi Y, Cavallero S, Patterson M, Shen H, Xu J, Kumar SR, et al. Adipogenesis and epicardial adipose tissue: A novel fate of the epicardium induced by mesenchymal transformation and PPAR-gamma activation. Proc Natl Acad Sci USA 2015; 112: 2070–2075.
113. Liu Q, Huang X, Oh JH, Lin RZ, Duan S, Yu Y, et al. Epicardium-to-fat transition in injured heart. Cell Res 2014; 24: 1367.
114. Zeng B, Ren XF, Cao F, Zhou XY, Zhang J. Developmental patterns and characteristics of epicardial cell markers Tbx18 and Wt1 in murine embryonic heart. J Biomed Sci 2011; 18: 1.
115. Duim SN, Kurakula K, Goumans MJ, Kruithof BP. Cardiac endothelial cells express Wilms’ tumor-1: Wt1 expression in the developing, adult and infarcted heart. J Mol Cell Cardiol 2015; 81: 127–135.
116. Robb L, Mifsud L, Hartley L, Biben C, Copeland NG, Gilbert DJ, et al. epicardin: A novel basic helix-loop-helix transcription factor gene expressed in epicardium, branchial arch myoblasts, and mesenchyme of developing lung, gut, kidney, and gonads. Dev Dyn 1998; 213: 105–113.
117. Matthijs Blankesteijn W. Has the search for a marker of activated fibroblasts finally come to an end? J Mol Cell Cardiol 2015; 88: 120–123.
118. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130: 393–405.
119. Pilling D, Fan T, Huang D, Kaul B, Gomer RH. Identification of markers that distinguish monocyte-derived fibrocytes from mono-cytes, macrophages, and fibroblasts. PLoS One 2009; 4: e7475, doi:10.1371/journal.pone.0007475.
120. Lane EB, Hogan BL, Kurkinen M, Garrels JI. Co-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature 1983; 303: 701–704.
121. Franke WW, Schmid E, Osborn M, Weber K. Intermediate-sized filaments of human endothelial cells. J Cell Biol 1979; 81: 570–580.
122. Yuan SM. Alpha-smooth muscle actin and ACTA2 gene expressions in vasculopathies. Braz J Cardiovasc Surg 2015; 30: 644–649.
123. Clement S, Stouffs M, Bettiol E, Kampf S, Krause KH, Chaponnier C, et al. Expression and function of alpha-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation. J Cell Sci 2007; 120: 229–238.
124. Kang J, Gu Y, Li P, Johnson BL, Sucov HM, Thomas PS. PDGF-A as an epicardial mitogen during heart development. Dev Dyn 2008; 237: 692–701.
125. Moore-Morris T, Cattaneo P, Puceat M, Evans SM. Origins of cardiac fibroblasts. J Mol Cell Cardiol 2016; 91: 1–5.
126. Morales MO, Price RL, Goldsmith EC. Expression of Discoidin Domain Receptor 2 (DDR2) in the developing heart. Microsc Microanal 2005; 11: 260–267.
127. Shyu KG, Chao YM, Wang BW, Kuan P. Regulation of discoidin domain receptor 2 by cyclic mechanical stretch in cultured rat vascular smooth muscle cells. Hypertension 2005; 46: 614–621.
128. DeLeon-Pennell KY. May the fibrosis be with you: Is discoidin domain receptor 2 the receptor we have been looking for? J Mol Cell Cardiol 2016; 91: 201–203.
129. Vitetta ES, Boyse E, Uhr J. Isolation and characterization of a molecular complex containing thy-1 antigen from the surface of murine thymocytes and t cells. Eur J Immunol 1973; 3: 446–453.
130. Wang X, Hu Q, Nakamura Y, Lee J, Zhang G, From AH, et al. The role of the sca-1+/CD31–cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 2006; 24: 1779–1788.
131. Valente M, Nascimento DS, Cumano A, Pinto-do OP. Sca-1+ cardiac progenitor cells and heart-making: A critical synopsis. Stem Cells Dev 2014; 23: 2263–2273.
132. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998; 142: 873–881.
133. Arslan F, Smeets MB, Riem Vis PW, Karper JC, Quax PH, Bongartz LG, et al. Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circ Res 2011; 108: 582–592.
134. Baek ST, Tallquist MD. Nf1 limits epicardial derivative expansion by regulating epithelial to mesenchymal transition and proliferation. Development 2012; 139: 2040–2049.